Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
   
   

The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.

 
Web www.patentalert.com

< Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound

< Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID

> Calcilytic compounds

> Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
~ 00130